Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Por:
Zapata-Cobo, Paula, Salvador-Matin, Sara, Velasco, Marta, Palomino, Laura M., Clemente, Susana, Segarra, Oscar, Moreno-Alvarez, Ana, Fernandez-Lorenzo, Ana, Perez-Moneo, Begona, Montraveta, Montse, Sanchez, Cesar, Tolin, Mar, Loverdos, Ines, Fobelo, Maria Jose, Navas-Lopez, Victor Manuel, Magallares, Lorena, Garcia-Romero, Ruth, Sanchez-Hernandez, Jose German, Rodriguez, Alejandro, Bossacoma-Busquets F, Balboa, Maria Jesus, Salcedo, Enrique, Sanjurjo-Saez, Maria and Lopez-Fernandez, Luis A.
Publicada:
1 oct 2023
Ahead of Print:
1 oct 2023
Categoría:
Pharmacology
Resumen:
gold
|